ConductScience.org, home

Paper41377642

Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions.

Edpuganti S and 4 others. Heart Int, 2025. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions. Papers, record 41377642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377642

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gut Microbiome and Cardiovascular Health: Mechanisms, Therapeutic Potential and Future Directions.
PubMed
Journal
Heart Int
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
3.79, provisional
iCite
Revised in PubMed
2025-12-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edpuganti SSudeep
2Subhash SShravan
3Subrahmaniyan SLSujitha Lekshmi
4Latheef SShifna
5Albarari SSShams Samih

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References100

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136524472Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure.Circ Heart Fail2023https://conductscience.org/library/papers/36524472PubMed
232762536Gut Microbiota and Cardiovascular Disease.Circ Res2020https://conductscience.org/library/papers/32762536PubMed
333689000The gut microbiome of laboratory mice: considerations and best practices for translational research.Mamm Genome2021https://conductscience.org/library/papers/33689000PubMed
436704458Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure.Front Cardiovasc Med2022https://conductscience.org/library/papers/36704458PubMed
526972052Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.Cell2016https://conductscience.org/library/papers/26972052PubMed
636982880Modulation of Endothelial Function by TMAO, a Gut Microbiota-Derived Metabolite.Int J Mol Sci2023https://conductscience.org/library/papers/36982880PubMed
740410854Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial.Microbiome2025https://conductscience.org/library/papers/40410854PubMed
839765880Polyphenol-Derived Microbiota Metabolites and Cardiovascular Health: A Concise Review of Human Studies.Antioxidants (Basel)2024https://conductscience.org/library/papers/39765880PubMed
934436434Exploring the Gut Microbiota and Cardiovascular Disease.Metabolites2021https://conductscience.org/library/papers/34436434PubMed
1037229456Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37229456PubMed
1133803407The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.Nutrients2021https://conductscience.org/library/papers/33803407PubMed
1231182162Sex, gut microbiome, and cardiovascular disease risk.Biol Sex Differ2019https://conductscience.org/library/papers/31182162PubMed
1330264354Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health.Curr Nutr Rep2018https://conductscience.org/library/papers/30264354PubMed
1440155609The regulatory framework for microbiome-based therapies: insights into European regulatory developments.NPJ Biofilms Microbiomes2025https://conductscience.org/library/papers/40155609PubMed
1536655084Long-term use of probiotics for the management of office and ambulatory blood pressure: A systematic review and meta-analysis of randomized, controlled trials.Food Sci Nutr2023https://conductscience.org/library/papers/36655084PubMed
1636768264Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?Int J Mol Sci2023https://conductscience.org/library/papers/36768264PubMed
1730782617Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial.Gut2019https://conductscience.org/library/papers/30782617PubMed
1833003455Gut Microbiota in Hypertension and Atherosclerosis: A Review.Nutrients2020https://conductscience.org/library/papers/33003455PubMed
1930410105Dietary metabolism, the gut microbiome, and heart failure.Nat Rev Cardiol2019https://conductscience.org/library/papers/30410105PubMed
2032010123Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy.Front Immunol2019https://conductscience.org/library/papers/32010123PubMed

See all 100 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42921018Gut microbiota-bile acid-immune axis: receptor signaling, metabolic regulation, and therapeutic translation.Front Immunol2026https://conductscience.org/library/papers/42921018PubMed
42865986New insights into the gut-heart axis: microbial metabolite biomarkers, multi-omics, and engineered bacterial delivery systems.Front Microbiol2026https://conductscience.org/library/papers/42865986PubMed
42769626Milk-derived extracellular vesicles in cardiovascular therapy: emerging biological functions and therapeutic perspectives.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42769626PubMed
42712928The gut microbiome-cardiometabolic axis: insights into obesity, type 2 diabetes, and hypertension.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42712928PubMed
42639235Metabolic Syndrome: From Mechanisms to Therapeutic Interventions.MedComm (2020)2026https://conductscience.org/library/papers/42639235PubMed
42609637The gut-heart axis: a review of the mechanisms and therapeutic prospects of gut microbiota and their metabolites in cardiovascular disease.Front Cardiovasc Med2026https://conductscience.org/library/papers/42609637PubMed
42416572Metabolic Dysfunction-Associated Steatotic Liver Disease as a Systemic Driver of Heart Failure With Preserved Ejection Fraction: Mechanistic Insights and Emerging Therapeutic Perspectives.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42416572PubMed
42353030Gut Microbiome-Hormone Interactions and Precision Fermentation in the Prevention of Early Cardiovascular Risk in Adolescents.Int J Mol Sci2026https://conductscience.org/library/papers/42353030PubMed
42351694Gut Microbiota as an Innovative Therapeutic Target in Cardiovascular Diseases from a Metabolic and Inflammatory Perspective.Biomedicines2026https://conductscience.org/library/papers/42351694PubMed
42305144Regenerative and molecular therapies for myocardial repair (Review).Med Int (Lond)2026https://conductscience.org/library/papers/42305144PubMed
42070004Medicinal Plants and the Gastrointestinal Microbiota in Chronic Diseases Modulation: A Structured Mechanistic and Translational Review.Curr Microbiol2026https://conductscience.org/library/papers/42070004PubMed
41598535Gut-Heart Axis and Infective Endocarditis: How Microbiota Dysbiosis Shapes Cardiovascular Risk and Infection Susceptibility.J Clin Med2026https://conductscience.org/library/papers/41598535PubMed
41596655Microbiota-Mediated Crosstalk Between the Gut and the Vascular System: Protective Effects of Novel Postbiotic Formulations on Human Endothelial and Vascular Smooth Muscle Cells.Int J Mol Sci2026https://conductscience.org/library/papers/41596655PubMed
41555935The Hepato-Cardio-Renal Axis in Cirrhosis: Hemodynamic and Mechanistic Insights, Diagnostic Biomarkers, and Expanding Therapeutic Horizons.Discoveries (Craiova)2025https://conductscience.org/library/papers/41555935PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41377642

GET https://conductscience.org/api/papers/v1/41377642/references?page=2